Jianxin Xue

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

You Lü, Jianxin Xue, Tao Deng et al. · Nature Medicine · 2020 · 510 citations

Off-target Effect, Medicine, Immunology +10

Effect of Low-Dose Radiation Therapy on Abscopal Responses to Hypofractionated Radiation Therapy and Anti-PD1 in Mice and Patients With Non-Small Cell Lung Cancer

Limei Yin, Jianxin Xue, Rui Li et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 131 citations

Radiation Therapy, Medicine, Hypofractionated Radiation Therapy +8

KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming

Feifei Na, Xiangyu Pan, Jingyao Chen et al. · Nature Cancer · 2022 · 112 citations · Full text

Chromatin, Medicine, Epigenetic Change +9

Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy

Jie Lan, Rui Li, Limei Yin et al. · International Journal of Radiation Oncology*Biology*Physics · 2018 · 105 citations

Radiation Therapy, Medicine, Myeloid-derived Suppressor Cells +6

Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model

Wenhao Guo, Yu Zhang, Ting Chen et al. · Journal of Cancer Research and Clinical Oncology · 2010 · 96 citations · Full text

Pyruvate Kinase M2, Oncology, Medicine +8